Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.
Also called NCT01750775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 330 participants
- Registry
-
NCT01750775
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01750775. Randomized; triple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions
- Acronym
- SS-SBVPT
- Condition
- Premature Ventricular Contraction
- Intervention (Drug)
- Shensong Yangxin capsule
- Intervention (Drug)
- placebo Capsule
- Lead sponsor
- kejiang Cao
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Third Military Medical University
Record details
- Record id
cardio:ct-nct01750775- Content hash
95b5e4ffdf83fcf71ef176b6af295438be2135de7d548afb111b0226c439e5b2